AI Article Synopsis

  • This study investigates the management of ocular surface disease (OSD) related to ocular cicatricial pemphigoid (OCP) at the University of Colorado Hospital, focusing on treatment effectiveness and patient outcomes.
  • A total of 30 patients with OCP were evaluated, revealing that common treatments included preservative-free artificial tears, topical corticosteroids, and autologous serum eye drops, with most patients requiring multiple therapies.
  • The findings suggest that as OCP severity increases, the need for more intensive OSD management also rises, emphasizing the importance of tailored treatments for advanced cases.

Article Abstract

Purpose: While substantial research has focused on systemic immunomodulatory therapy for ocular cicatricial pemphigoid (OCP), limited data exist on managing associated ocular surface disease (OSD). This study evaluates treatments for OCP-related OSD at our institution.

Methods: We conducted a retrospective analysis of patients diagnosed with cicatrizing conjunctivitis at the University of Colorado Hospital from January 1, 2013, to October 31, 2023. Patients with cicatrizing conjunctivitis due to non-OCP conditions were excluded, and disease severity was classified using the Foster Staging System.

Results: Our review included 30 patients with OCP, all with at least six months of follow-up. The mean age of symptom onset ( = 19) was 62.2 years (SD = 16.4), while the mean age at diagnosis ( = 28) was 65.1 years (SD = 12.7). The most common OSD treatments at the last visit were preservative-free artificial tears (87%), topical corticosteroids (43%), autologous serum eye drops (40%), topical antibiotics (30%), and topical immunomodulators (23%). All patients used at least one treatment, with 83.3% on prescription therapies. Patients averaged 3.33 (SD: 1.4) treatments, with 1.7 (SD: 1.2) being prescriptions. Topical immunomodulators had the highest discontinuation rate at 73.1% ( = 19/26). Autologous serum eye drops and topical corticosteroids were the least discontinued treatments. Number of total treatments, prescriptions, and procedures sharply increased at stage three OCP.

Conclusions: The number of treatments and procedures increased with OCP severity, indicating that advanced OCP often necessitated more intensive OSD management.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09273948.2024.2413892DOI Listing

Publication Analysis

Top Keywords

ocular surface
8
surface disease
8
ocular cicatricial
8
cicatricial pemphigoid
8
cicatrizing conjunctivitis
8
topical corticosteroids
8
autologous serum
8
serum eye
8
eye drops
8
topical immunomodulators
8

Similar Publications

Healing the Cornea: Exploring the Therapeutic Solutions Offered by MSCs and MSC-derived EVs.

Prog Retin Eye Res

December 2024

Regenerative Medicine Institute, School of Medicine, University of Galway, Galway, Ireland; CURAM Centre for Research in Medical Devices, University of Galway, Galway, Ireland. Electronic address:

Affecting a large proportion of the population worldwide, corneal disorders constitute a concerning health hazard associated to compromised eyesight or blindness for most severe cases. In the last decades, mesenchymal stem/stromal cells (MSCs) demonstrated promising abilities in improving symptoms associated to corneal diseases or alleviating these affections, especially through their anti-inflammatory, immunomodulatory and pro-regenerative properties. More recently, MSC therapeutic potential was shown to be mediated by the molecules they release, and particularly by their extracellular vesicles (EVs; MSC-EVs).

View Article and Find Full Text PDF

The role of lysophosphatidic acid and its receptors in corneal nerve regeneration.

Ocul Surf

December 2024

Laboratory of Experimental Ophthalmology, Department of Ophthalmology, Pius-Hospital, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Germany.

The integrity of corneal nerves is critical for ocular surface health, and damages can lead to Neurotrophic Keratopathy (NK). Despite the regenerative abilities of the peripheral nerve system (PNS), corneal nerve regeneration is often incomplete, and the underlying mechanisms are poorly understood. This study aims to identify potential factors that can enhance corneal nerve regeneration for NK treatment, with a focus on Lysophosphatidic acid (LPA).

View Article and Find Full Text PDF

Purpose: Graft-versus-host disease (GVHD) is a common complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). GVHD may affect several organs, including ocular manifestations, ranging from dry eye syndrome to sight-threatening corneal ulceration or perforation. Limited information is available about characteristics and treatments of ocular GVHD and its relation to general prognosis.

View Article and Find Full Text PDF

Gellan gum-based in-situ gel formulations for ocular drug delivery: A practical approach.

Int J Biol Macromol

December 2024

Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 761003, India. Electronic address:

Ophthalmic disorders significantly impact global health, affecting millions worldwide. Conventional treatments often face challenges related to poor bioavailability and short residence times on the ocular surface. In recent years, in-situ gels prepared using different natural gums including gellan gum has been investigated as a viable means of improving ocular medication delivery.

View Article and Find Full Text PDF

Purpose: To evaluate the clinical outcomes of implanting two symmetrical Kerarings via a femtosecond laser in grade three keratoconus.

Patients And Methods: This was a retrospective nonrandomized controlled clinical study. The study included one eye from each of twenty-three patients, all with Grade 3 keratoconus as classified by the Amsler-Krumeich classification.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!